University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

Breast Oncology Retreat 2018

BOP keynote roomThursday, February 22, 2018
9:00 am - 6:00 pm

Jewish Community Center of San Francisco
3200 California Street
San Francisco, CA 94118

Overview | Agenda | Registration | Poster Registration

Compete to Present a Pitch | Directions | Contact



Download the Poster Abstract Handout


View and download the POSTER ABSTRACT HANDOUT.

Please note that hard copies of the abstracts will not be distributed at the event.



Overview

The 2018 retreat includes: two thematic sessions that will grapple with important challenges in breast cancer prevention and treatment, one brief session sharing the latest hot topics in breast cancer science, and an interactive poster session to ensure the full breadth of work is shared within our community.

This format provides several opportunities to participate:

  1. Compete to give a podium presentation. Four speakers will be selected by competition to present a "pitch" during one of the two-hour sessions that address controversial questions in breast cancer. View instructions and submit a pitch by February 12th here.
  2. Register a poster. All poster session abstracts will be reviewed by a committee that will select the best submissions in each category. The author of the top poster in each category will give a ten minute talk, and all posters will be displayed in the two poster sessions.

All are welcome to attend the BOP 2018 Retreat! Advance registration is required.


Agenda

8:30 - 9:00 am

Registration and Breakfast (Atrium)

9:00 - 9:05 am

Welcome and Introduction (Kanbar Hall)
Laura van ‘t Veer, PhD

How to Treat Breast Cancer and Improve Patient Outcomes (Moderator: Hope Rugo, MD)

9:05 - 9:15 am

BSAC Perspective
Amy Delson, UCSF Breast Science Advocate

9:15 - 9:35 am

Facts of topic and pitch
Mark Pegram, MD, Stanford University Cancer Center

9:35 - 9:55 am

Facts of topic and pitch
Larry Norton, MD, Memorial Sloan Kettering Cancer Institute

9:55 - 10:15 am

Facts of topic and pitch
Douglas Yee, MD, Masonic Cancer Center, University of Minnesota

10:15 - 10:25 am

Views and pitch
Alan Ashworth, PhD, FRS, President, UCSF Helen Diller Family Comprehensive Cancer Center

10:25 - 10:35 am

Views and pitch
Ella Jones, PhD / Nola Hylton, PhD, UCSF

10:35 - 10:45 am

Views and pitch
Michelle Melisko, MD, UCSF

10:45 - 11:15 am

Speaker panel and discussion with audience

11:15 - 11:30 am

Break

UCSF Science Hot Topics (Moderator: Mary-Helen Barcellos-Hoff, PhD)

11:30 - 11:45 am

Cancer immune orchestration
Matthew Spitzer, PhD, UCSF

11:45 am - 12:00 pm

Gut bacteria producing enteralactone may have breast cancer-protective effects
Elizabeth Bess, PhD, UCSF

12:00 - 12:15 pm

Artificial intelligence for big data patterns
Bin Chen, PhD, UCSF

12:15 - 12:30 pm

Pathologic ncRNA in a top-down reductionist framework
Hani Goodarzi, PhD, UCSF

12:30 - 1:30 pm

**Lunch & Poster Interaction Session (Atrium)**

Recognizing Who Is at Risk and Determining How to Prevent Breast Cancer (Moderator: Laura van ‘t Veer, PhD)

1:30 pm - 1:50 pm

Facts of topic and pitch
Ami Bhatt, MD, PhD, Stanford University

1:50 - 2:10 pm

Facts of topic and pitch
Lisa Madlensky, PhD, CGC, UC San Diego

2:10 - 2:30 pm

Facts of topic and pitch
Laura Esserman, MD, MBA, UCSF

2:30 - 2:40 pm

BSAC perspective
Diane Heditsian, UCSF Breast Science Advocate

2:40 - 2:50 pm

Views and pitch
Valerie Weaver, PhD, UCSF

2:50 - 3:00 pm

Views and pitch
Mark Magbanua, PhD, UCSF

3:00 - 3:30 pm

Speaker panel and discussion with audience

3:30 - 3:45 pm

Break

Poster Discussion Session (Moderator: Mark Moasser, MD)

3:45 - 3:55 pm

Detection and Biomarkers #4 (Biomarkers)
Hayley Donnella, BSc

3:55 - 4:05 pm

Molecular and Cellular Biology #6
Jason Northey, PhD

4:05 - 4:15 pm

Detection and Biomarkers #2 (Detection-Imaging)
Ella Jones, PhD

4:15 - 4:30 pm

Discussant Mark Moasser, MD and General Discussion

4:30 - 4:40 pm

Therapeutics and Clinical Trials #4
Zelos Zhu, BSc

4:40 - 4:50 pm

Epidemiology and Population Science #2
Kenneth Wimmer, BSc

4:50 - 5:05 pm

Discussant Yiwey Shieh, MD and General Discussion

5:05 - 5:10 pm

Poster Awards

5:10 - 6:00 pm

**Poster Session (Atrium)**

Light refreshments and beverages will be served.


Registration


**Registration is now closed.**


Poster Registration


**Poster registration is now closed.**

**View and download the POSTER ABSTRACT HANDOUT**

The intent of the poster session is to generate interest in current projects and facilitate communications between program members. Posters may have been presented previously at other meetings.

The session categories are:

  • Detection and Biomarkers
  • Epidemiology and Population Sciences
  • Molecular and Cell Biology
  • Therapeutics and Clinical Trials

Awards will be given. Note the following:

  • A lay person will be included in the review of your submission. Please explain abbreviations and consider the perspective of a sophisticated non-scientist.
  • You will be judged on the abstract you submit, so you should provide sufficient detail. Communicating your material clearly is important.
  • Please consider working with your PI for advice and guidance as you prepare your submission.
  • The author of the top poster in each category will give a ten minute talk. If selected you will be notified by February 16.
  • A PDF of last year's winning poster abstracts is available. Please contact vantveer.admin@ucsf.edu if you would like a copy.

Size and Display Guidelines

  • Posters must be preregistered.
  • Posters board stands will be available well before the poster session begins. Event participants may display their work as soon as the boards are labeled with designated poster numbers, and posters must be installed prior to the 12:30 pm lunch start time.
  • We encourage participants to bring a poster to fit in an 4’x 4’ area. Larger 4’x8’ (horizontal “landscape” orientation) will be provided for those who require it to display an existing poster of that size.
  • Posters should be affixed with pushpins (provided) on the assigned, freestanding poster frame. Use lightweight materials that will affix easily with pushpins. Include the title and authors at the top of the posters in 1-inch-high letters. Keep illustrated material simple and make posters as self-explanatory as possible.
  • Detailed directions for setting up posters on event day (February 22) will be provided at a later date by email to all registered poster contacts.
  • You will be required to submit an abstract of 350 words or less.

All entries must be submitted by Friday, February 9th.


Competition to "Present a Pitch"


**To be considered to give a pitch, please send a one-paragraph proposal outlining the topic you would like to present to vantveer.admin@ucsf.edu by February 12.**

Four speakers will be selected by competition to present a ‘pitch’ at the retreat. Two in the "How to Treat Breast Cancer and Improve Patient Outcomes" session and two in the "Recognizing Who Is at Risk and Determining How to Prevent Breast Cancer" session. Pitch proposals should be focused on presenting cutting edge ideas. If selected you will present a ‘pitch’ and participate in the moderated panel discussion that will dive deeper into the presented facts and ideas.


Directions

  • Parking: Self-paid parking is available in the garage located on-site. Pay inside at the JCC information desk to receive event pricing. Those with UCSF parking permits can park across the street at Laurel Heights.
  • Public Transportation: UCSF staff, students, and faculty may take one of the campus shuttles to the adjacent Laurel Heights campus. The Jewish Community Center is accessible by public transportation (including MUNI bus lines 1, 2, 4). 

Contact

Contact Vantveer Admin for questions or more information about the event.

If you are interested in joining the UCSF Breast Oncology Program email list for regular updates, please send a request to Vantveer Admin

**This retreat is supported in part by Puma Biotechnology, Inc., an educational grant from Daiichi Sankyo, Inc., and AstraZeneca.**